Literature DB >> 943040

Reversal of advanced digoxin intoxication with Fab fragments of digoxin-specific antibodies.

T W Smith, E Haber, L Yeatman, V P Butler.   

Abstract

Purified Fab fragments of ovine digoxin-specific antibodies reversed severe digoxin intoxication in a patient who had taken 22.5 mg of the drug with suicidal intent. Atrioventricular block with extreme bradycardia was temporarily managed by pacing, but progressive, intractable hyperkalemia (serum potassium of 8.7 meq per liter) with increasing pacing threshold and progressive intraventricular conduction delay was controlled only after infusion of 1100 mg of Fab. Sinus rhythm returned 10 minutes after completion of Fab infusion. Within five hours, the serum potassium concentration fell to 4.0 meq per liter. Free digoxin concentrations in serum fell sharply to undetectable levels, whereas total serum digoxin concentration concomitantly increased 12-fold. Renal excretion of digoxin bound to Fab was documented. Reversal of toxicity was not accompanied by hemodynamic instability, and antibodies to sheep Fab fragments were not detected in the patient's serum after treatment. Thus, purified digoxin-specific Fab fragments are capable of rapid reversal of advanced digoxin toxicity.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 943040     DOI: 10.1056/NEJM197604082941501

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  58 in total

1.  Immunotherapeutic approach to management of toxic drug reaction.

Authors:  R C Watkins
Journal:  J Natl Med Assoc       Date:  1991-03       Impact factor: 1.798

2.  Fatal digoxin overdose.

Authors:  D P Nicholls
Journal:  Postgrad Med J       Date:  1977-05       Impact factor: 2.401

3.  A star treatment for digoxin overdose?

Authors:  A T Proudfoot
Journal:  Br Med J (Clin Res Ed)       Date:  1986-09-13

4.  Reversal of toxic and non-toxic effects of digoxin by digoxin-specific Fab fragments in isolated human ventricular myocardium.

Authors:  M Näbauer; E Erdmann
Journal:  Klin Wochenschr       Date:  1987-07-15

5.  Severe digoxin intoxication in a child treated by infusion of digoxin-specific Fab-antibody-fragments.

Authors:  R Rossi; J U Leititis; K J Hagel; A Smolarz; M Brandis
Journal:  Eur J Pediatr       Date:  1984-06       Impact factor: 3.183

6.  A specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor Xa.

Authors:  Genmin Lu; Francis R DeGuzman; Stanley J Hollenbach; Mark J Karbarz; Keith Abe; Gail Lee; Peng Luan; Athiwat Hutchaleelaha; Mayuko Inagaki; Pamela B Conley; David R Phillips; Uma Sinha
Journal:  Nat Med       Date:  2013-03-03       Impact factor: 53.440

7.  Assessment of digoxin antibody use in patients with elevated serum digoxin following chronic or acute exposure.

Authors:  Frédéric Lapostolle; Stephen W Borron; Carine Verdier; Fabrice Arnaud; James Couvreur; Bruno Mégarbane; Frédéric Baud; Frédéric Adnet
Journal:  Intensive Care Med       Date:  2008-04-04       Impact factor: 17.440

Review 8.  Immunotherapy in the poisoned patient. Overview of present applications and future trends.

Authors:  J B Sullivan
Journal:  Med Toxicol       Date:  1986 Jan-Feb

9.  The influence of digoxin antibodies on digoxin disposition and effect: studies in guinea-pigs and HeLa cells.

Authors:  N M Griffiths; D S Hewick; J F Lamb; I H Stevenson
Journal:  Br J Pharmacol       Date:  1985-01       Impact factor: 8.739

10.  Effects of sheep digoxin-specific antibodies and their Fab fragments on digoxin pharmacokinetics in dogs.

Authors:  V P Butler; D H Schmidt; T W Smith; E Haber; B D Raynor; P Demartini
Journal:  J Clin Invest       Date:  1977-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.